LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 86.03 | 21.74 | 529 | 6155 | 0.0859 | 0.4797 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 88.00 | 21.74 | 34 | 6081 | 0.0056 | 0.0566 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 88.00 | 21.74 | 683 | 6081 | 0.1123 | 0.5283 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 88.00 | 21.74 | 1 | 6081 | 0.0002 | -0.3153 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 88.00 | 21.74 | 515 | 6081 | 0.0847 | 0.4761 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 89.97 | 21.74 | 29 | 6084 | 0.0048 | 0.0361 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 89.97 | 21.74 | 678 | 6084 | 0.1114 | 0.5268 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 89.97 | 21.74 | 1 | 6084 | 0.0002 | -0.3153 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 89.97 | 21.74 | 474 | 6084 | 0.0779 | 0.4611 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 91.94 | 21.74 | 31 | 6121 | 0.0051 | 0.0446 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 91.94 | 21.74 | 667 | 6121 | 0.1090 | 0.5231 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 91.94 | 21.74 | 1 | 6121 | 0.0002 | -0.3150 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 91.94 | 21.74 | 456 | 6121 | 0.0745 | 0.4535 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 93.92 | 21.74 | 28 | 6070 | 0.0046 | 0.0316 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 93.92 | 21.74 | 659 | 6070 | 0.1086 | 0.5218 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 93.92 | 21.74 | 1 | 6070 | 0.0002 | -0.3154 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 93.92 | 21.74 | 454 | 6070 | 0.0748 | 0.4536 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Etoposide | 0.0010833 | 2.24 | 21.74 | 1 | 183 | 0.0054 | -0.6323 | MN20160310_N01 | I10 |
| MCF 10A-H2B-mCherry | Etoposide | 0.0010833 | 2.24 | 21.74 | 676 | 183 | 3.6825 | 2.0547 | MN20160310_N01 | I10 |
| MCF 10A-H2B-mCherry | Etoposide | 0.0010833 | 2.24 | 21.74 | 1 | 183 | 0.0054 | -0.6323 | MN20160310_N01 | N17 |
| MCF 10A-H2B-mCherry | Etoposide | 0.0010833 | 2.24 | 21.74 | 671 | 183 | 3.6553 | 2.0473 | MN20160310_N01 | N17 |
| MCF 10A-H2B-mCherry | Etoposide | 0.0010833 | 4.24 | 21.74 | 1 | 317 | 0.0031 | -0.5487 | MN20160310_N01 | I10 |
| MCF 10A-H2B-mCherry | Etoposide | 0.0010833 | 4.24 | 21.74 | 864 | 317 | 2.7188 | 1.5899 | MN20160310_N01 | I10 |
| MCF 10A-H2B-mCherry | Etoposide | 0.0010833 | 4.24 | 21.74 | 1 | 317 | 0.0031 | -0.5487 | MN20160310_N01 | N17 |
| MCF 10A-H2B-mCherry | Etoposide | 0.0010833 | 4.24 | 21.74 | 752 | 317 | 2.3664 | 1.4986 | MN20160310_N01 | N17 |